.svg)
FAMAR is proud to be featured on SR Fernsehen as part of the “Farmaland Saarland” series, highlighting the strategic acquisition of the former MIP Pharmaceutical Group production site in Homburg in 2025.
This facility plays a critical role in the manufacture of large volumes of essential medicines, with a strong focus on antibiotics and sterile injectable forms.
The reportage showcases not only our growing presence in the region, but also our commitment to sustainable development. This momentum is reflected in the significant expansion of the team over the next two years, driven by ongoing site development and the enhancement of capabilities. Combined with capacity expansion initiatives, these developments will further strengthen Homburg’s position as a key hub within FAMAR’s European network.
Equally important, the feature highlights the robust quality systems and rigorous controls in place to meet the highest pharmaceutical standards, ensuring every product delivered is safe, effective, and compliant.
A big thank you to SR Fernsehen for the opportunity to share this important milestone and to highlight the people and processes that make it possible.
